AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇬🇭

Dolutegravir Sodium in Ghana

7 products registered with FDA Ghana 6 active, 1 expired

Brand / ProductReg. No.HolderStatusExpires
Dolutegravir Tablet (each film coated tablet contains Dolutegravir sodium 50mg)UNKNOWN-4dd9e896active22 Feb 2030
Dolutegravir Tablet (each film coated tablet contains Dolutegravir sodium 50mg)UNKNOWN-da5b9392active22 Feb 2030
DOLUTEGRAVIR 50MG TABLETSUNKNOWN-2762a220active1 Dec 2029
DOLUTEGRAVIR 50MG TABLETSUNKNOWN-acf38d27active1 Dec 2029
DOLUTEGRAVIR​ SODIUM TABLETS FOR ORAL SUSPENSION 10mgUNKNOWN-37ae8561active1 Sept 2029
DOLUTEGRAVIR​ SODIUM TABLETS FOR ORAL SUSPENSION 10mgUNKNOWN-868a71ffactive1 Sept 2029
TABLETS (Each tablet contains Dolutegravir Sodium 500mg)UNKNOWN-74df6303MYLAN LABORATORIES LIMITED; PLOT NO. 11,12 & 13 INDARE SEZ PHARMA ZONE PHASE II SECTOR III DIST. DHAR PITHAMPUR MADHYA PRADESH 45775 INDIAexpired1 Jun 2026

Dolutegravir SodiumFDA Ghana Registration Details

FDA Ghana (Ghana) has 7 registered products containing Dolutegravir Sodium, of which 6 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.

Track Dolutegravir Sodium registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.